Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 7.00M | £ 0.00 | £ 6.80M | £ 11.10M | £ 7.20M |
Total Assets | £ 2.73B | £ 2.76B | £ 2.56B | £ 2.56B | £ 2.54B |
Total Debt | £ 679.40M | £ 589.70M | £ 489.50M | £ 533.20M | £ 454.50M |
Net Debt | £ 672.40M | £ 589.70M | £ 482.70M | £ 522.10M | £ 447.30M |
Total Liabilities | £ 720.10M | £ 644.90M | £ 542.80M | £ 588.30M | £ 511.30M |
Stockholders Equity | £ 2.01B | £ 2.11B | £ 2.02B | £ 1.97B | £ 2.03B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |